Search clinical trials for: Promus element, Xience prime, and Nobori

Total 71 results

San Giuseppe Moscati Hospital

Completed

Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction

ST Elevation Acute Myocardial Infarction

Italy
Yonsei University
Gangwon Cardiovascular Health Research Institute

Terminated

BES, EES, and ZES-R in Real World Practice (CHOICE)

Coronary Artery Disease

Korea, Republic of
The Hospital District of Satakunta

Completed

Vascular Healing After Deployment of Titanium-nitride-oxide-coated OPTIMAX™ Stent and PROMUS-ELEMENT™ Everolimus-Eluting Stent (TIDES-OCT)

Acute Coronary Syndrome

Finland
Seoul National University Hospital
Boston Scientific Corporation; Abbott

Unknown

Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing (EXCELLENT)

Coronary Artery Disease

Korea, Republic of
Meshalkin Research Institute of Pathology of Circulation

Completed

Sirolimus-eluting Stent CALYPSO vs Everolimus-eluting Stent XIENCE (PATRIOT)

Coronary Artery Disease | Ischemic Heart Disease | Coronary Atherosclerosis | Coronary Artery Stenosis

Russian Federation
Duk-Woo Park, MD
CardioVascular Research Foundation, Korea

Terminated

Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease (ABSORB-LONG)

Percutaneous Transluminal Coronary Angioplasty

Korea, Republic of
Francesca De Filippis

Completed

Characterization of a Population Living in Highly Contaminated Settlement in Campania Region (SPES)

Environmental-Pollution-Related Condition
Abbott Medical Devices

Completed

XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE PRIME SV Japan PMS)

Myocardial Ischemia | Coronary Artery Disease | Angina Pectoris | Ischemic Heart Disease | Coronary Artery Occlusion

Japan
Yonsei University

Completed

Intravascular ULTrasound Guided Versus Conventional Angiography Guided Strategy to Deploy Zotarolimus and Everolimus Eluting Third Generation Stents in the Long Coronary Artery Lesions: ULTRA-ZET Trial

Coronary Artery Disease

Korea, Republic of
Seoul National University Hospital
Boston Scientific Corporation

Unknown

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen (HOST-ASSURE)

Coronary Heart Disease

Korea, Republic of
Boston Scientific Corporation

Completed

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions (PLATINUM)

Coronary Artery Disease

United States, Denmark, Australia, Germany, Belgium, Finland, Netherlands, New Zealand, France, United Kingdom, Malaysia, Japan, Singapore, Poland, Latvia, Austria, Portugal
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Firehawk Rapamycin Target Eluting Coronary Stent North American Trial (TARGET-IV_NA)

Coronary Artery Disease

United States, Denmark, Canada, Belgium, Netherlands
Boston Scientific Corporation

Active, not recruiting

PROMUS PREMIER™ China Post-Approval Study

Coronary Artery Disease

China
Boston Scientific Corporation

Completed

PROMUS Element Plus US Post-Approval Study

Coronary Artery Disease

United States
Central Clinical Hospital of the Ministry of Internal...

Completed

DES Versus BiOSS LIM - POLBOS II Study (POLBOS II)

Coronary Artery Disease

Poland
Yonsei University

Completed

Serial EValuation of multiplE Coronary Artery Diseases by an Optical Coherence Tomography; Assessment of the Changes of de Novo Lesions and Comparisons of Neointimal Coverage Between Xience Prime® Versus Cypher SelectTM Stents; SEVEN-Xience Study

Multi-vessel Diseases, Angina

Korea, Republic of
CHEOL WHAN LEE, MD, PhD.
CardioVascular Research Foundation, Korea

Completed

Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)

Coronary Artery Disease

Korea, Republic of
University of Florida

Enrolling by invitation

Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia

Spasmodic Dysphonia

United States
Boston Scientific Corporation

Completed

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL) (PLATINUM LL)

Coronary Artery Disease

United States, Australia, Latvia, Belgium, France, New Zealand, Japan
Boston Scientific Corporation

Completed

PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK) (PLATINUM PK)

Coronary Artery Disease

United States, Japan
IHF GmbH - Institut für Herzinfarktforschung
OrbusNeich

Withdrawn

COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials (COSTA)

Coronary Disease | Stable Angina | Unstable Angina | STEMI | NSTEMI

Germany

Search clinical trials for: Promus element, Xience prime, and Nobori

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations